Literature DB >> 9124622

Mammographic assessment of the symptomatic nonsuspicious breast.

M J Kerin1, D M O'Hanlon, A A Khalid, P J Kent, P A McCarthy, H F Given.   

Abstract

BACKGROUND: Evidence from breast screening programs demonstrates the value of mammography in the detection of asymptomatic breast cancer.
METHODS: This study prospectively assessed the role of mammography in the management of 585 patients presenting to a breast clinic, over a 1-year period, with symptomatic breast disease and without clinical or cytological evidence of malignancy.
RESULTS: Eighteen (3%) of these patients had breast cancer. Eight patients presenting with nonspecific nodularity had carcinoma. All patients had relatively early disease.
CONCLUSIONS: This study suggests that patients with symptomatic disease presenting to a breast clinic represent a group at higher risk of malignancy than screened asymptomatic patients, and that symptomatic women over 40 years of age should have bilateral mammography before being discharged from the breast clinic.

Entities:  

Mesh:

Year:  1997        PMID: 9124622     DOI: 10.1016/s0002-9610(97)89591-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Mammography in symptomatic women attending a rapid diagnosis breast clinic: a prospective study.

Authors:  M J P Biggs; D Ravichandran
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

2.  The effect of imaging on the clinical management of breast pain.

Authors:  Mary Beth Howard; Tracy Battaglia; Marianne Prout; Karen Freund
Journal:  J Gen Intern Med       Date:  2012-01-31       Impact factor: 5.128

3.  Incidental breast cancers identified in the one-stop symptomatic breast clinic.

Authors:  Pallavi Mehrotra; Alice Townend; Linsley Lunt
Journal:  J Breast Cancer       Date:  2011-03-31       Impact factor: 3.588

4.  Association of symptoms and breast cancer in population-based mammography screening in Finland.

Authors:  Deependra Singh; Nea Malila; Arun Pokhrel; Ahti Anttila
Journal:  Int J Cancer       Date:  2014-09-04       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.